NASDAQ: PPCB
Propanc Biopharma Inc Stock Ownership - Who owns Propanc Biopharma?

Insider buying vs selling

Have Propanc Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PPCB insiders and whales buy or sell their stock.

PPCB Shareholders

What type of owners hold Propanc Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janstr0.00%26$12.84Institution
Jane Street Group LLC0.00%25$12.35Institution
Citade0.00%12$5.93Institution
Citadel Advisors LLC0.00%12$5.93Institution
Hrtfin0.00%10$4.94Institution
Hrt Financial LP0.00%10$4.94Institution
Mercer Global Advisors Inc0.00%0$0.00Institution
Caitong International Asset Management Co Ltd0.00%0$0.00Institution
Mercer0.00%0$0.00Institution
Caiton0.00%0$0.00Institution

1 of 1

PPCB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PPCB0.00%0.00%
APVO0.00%100.00%Net BuyingNet Selling
REVB0.00%100.00%Net Buying
HCWB0.01%34.14%Net BuyingNet Buying
VIVS0.00%100.00%Net BuyingNet Buying

Propanc Biopharma Stock Ownership FAQ

Who owns Propanc Biopharma?

Propanc Biopharma (NASDAQ: PPCB) is owned by 0.00% institutional shareholders, 0.00% Propanc Biopharma insiders, and 100.00% retail investors. Janstr is the largest individual Propanc Biopharma shareholder, owning 26.00 shares representing 0.00% of the company. Janstr's Propanc Biopharma shares are currently valued at $13.03.

If you're new to stock investing, here's how to buy Propanc Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.